NCT04871503 is a NA clinical trial of BTL-899 Buttocks in Muscle Tone, sponsored by BTL Industries Ltd..

Who is sponsoring NCT04871503?

NCT04871503 is sponsored by BTL Industries Ltd..

What drugs are being tested in NCT04871503?

Interventions in NCT04871503: BTL-899 Buttocks.

What condition does NCT04871503 study?

NCT04871503 studies Muscle Tone.

Is NCT04871503 still recruiting?

NCT04871503 is currently completed. Last updated 9 February 2022.

Last reviewed 2022-02-09 · How we verify

NCT04871503

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

High-Intensity Focused Electromagnetic Procedure and Radiofrequency for Toning of Buttocks

Completed NA Last updated 9 February 2022

What this trial tests

NA trial testing BTL-899 Buttocks in Muscle Tone in 67 participants. Completed in 12 January 2022.

Timeline

1 March 2021

Primary endpoint
6 October 2021

12 January 2022

Quick facts

Lead sponsor	BTL Industries Ltd.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	67
Start date	1 March 2021
Primary completion	6 October 2021
Estimated completion	12 January 2022
Sites	5 locations across United States

Drugs / interventions tested

BTL-899 Buttocks

Conditions studied

Muscle Tone — all drugs for Muscle Tone →

Sponsor

BTL Industries Ltd. — full company profile →

Who can join

Adults 21 to 70, any sex, with Muscle Tone. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the clinical efficacy and safety of the BTL-899 device for toning of buttocks. The study is a prospective multi-center open-label two-arm study. The subjects will be enrolled and assigned into two study groups. The subjects will be enrolled and assigned into two study groups; HIFEM+RF (HR) and HIFEM (H) group. Subjects of both groups will be required to complete four (4) treatment visits and two follow-up visits.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

High-Intensity Focused Electromagnetic Field With Synchronized Radiofrequency Achieves Superior Gluteal Muscle Contouring Than High-Intensity Focused Electromagnetic Field Procedure Alone.
DiBernardo B, Chilukuri S, McCoy JD, Katz B, et al · · 2023 · cited 5× · PMID 36654971 · DOI 10.1093/asjof/ojac087

Verify or expand the search:

Other recruiting trials for Muscle Tone

Currently open trials in the same condition.

NCT07472010 — Mandibular Stretching and 4-4-8 Breathing Exercises on Autonomic Nervous System Activity · NA · recruiting
NCT07094971 — Pure Impact Treatment to Strengthen and Tone Abdomen, Quadriceps and Glutes Muscles · NA · recruiting
NCT06970522 — Wearable Sensors to Detect Atypical Muscle Activation in Young Infants · recruiting
NCT06875453 — De Tethering Exercises for Scolisis · NA · active not recruiting

Other BTL Industries Ltd. trials

Trials by the same sponsor.

NCT07413692 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence in Postpartum and E · NA · recruiting
NCT07413705 — BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and · NA · recruiting
NCT07179224 — EEG Changes After rTMS Stimulation · NA · completed
NCT07024550 — Impact of the EXOMIND (BTL-699-2) on the Brain Reward Pathway · NA · active not recruiting
NCT07027657 — EXOMIND (BTL-699-2) for the Improvement of Sleep Quality and Reduction of Stress · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04871503 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by BTL Industries Ltd.
Last refreshed: 9 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04871503.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing